SynBioBeta 2026 is a conference that explores the intersection of synthetic biology, AI, and biotechnology to drive innovation in health, sustainability, and biomanufacturing.
Key Topics
AI-powered drug discovery
Cell and gene therapies
Engineered cells, tissues, and therapeutics
Predictive design for drugs, materials, and sustainable systems
Sequencing, synthesis, and editing technologies
Automation and cloud laboratories
BioCAD, ELNs, and data platforms
Continuous and precision fermentation
Modular and scalable bioprocesses
Cost-competitive, low-carbon biomanufacturing
Food and agriculture innovations
Climate tech and environmental solutions
Chemicals and materials design
Space exploration applications
Funding, partnerships, and investor insights
Regulatory, IP, and bioeconomy strategy
Commercialization and market scaling of biotech products
Shared data and tooling for programmable biology
Who should Attend
Synthetic biology researchers and practitioners
Biotechnology and biomanufacturing professionals
Pharmaceutical and therapeutic developers
AI and computational biology specialists
Environmental and sustainability innovators
Investors and venture capitalists in biotech
Regulatory and IP advisors
Academics, educators, and industry thought leaders
Past Events
SynBioBeta 2026 - 04-07 May 2026, San Jose McEnery Convention Center, California, United States (107870)
SynBioBeta 2027
Important
Please, check "SynBioBeta" official website for possible changes, before making any traveling arrangements